Recently, New York-based investment bank Cowen & Co. released a study on the CBD (cannabidiol) market. Of the findings, one of the most intriguing was that nearly 7 percent of the 2,500 polled, said they had used CBD, an active ingredient in marijuana that purportedly provides relief to patients without getting them high, as a supplement. This figure was far higher than what the Cowen analysts had expected.
Yet even more fascinating was the projected estimate Cowen analysts made about the revenue of this market--$16 billion by 2025. This number is a marked jump from the estimated retail sales of CBD consumer products in 2018 that ranged between $600 million and $2 billion.
RELATED: Brightfield Group Predicts Hemp-Derived CBD Market to Hit $22 Billion by 2022
Latest from Cannabis Business Times
- Cannabis Industry Reacts to Biden’s Rescheduling Announcement
- As Predicted, 4/20 Sales Surged During Cannabis Industry Holiday Weekend
- DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption
- Nature's Miracle, Agrify Sign Definitive Merger Agreement
- 5 Things to Confirm When Signing a Cannabis Facility Construction Agreement
- Ziel Partners With Portocanna, Receives 1st EU GMP Certification for Microbial Control Technology in Cannabis
- White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says
- SOMAÍ Group, and Its Subsidiary, RPK Biopharma Expand Cookies Partnership to Include Europe and the UK